Engineering in vitro models of hepatofibrogenesis

Area of Science:

• Hepatology
• Cell Biology
• Biomaterials Science

Background:

• Chronic liver disease causes significant global morbidity and mortality.
• Hepatic stellate cells (HSCs) drive liver fibrosis by excessive extracellular matrix (ECM) production.
• Current anti-fibrotic therapies remain largely undeveloped despite decades of research.

Purpose of the Study:

• To explore the utility of advanced three-dimensional (3D) in vitro models for studying liver fibrosis.
• To investigate the role of cell-matrix biomechanics and cell-cell interactions in liver fibrogenesis.
• To identify new therapeutic targets for antifibrotic compounds.

Main Methods:

• Development of well-defined 3D in vitro liver models mimicking in vivo ECM structures.
• Analysis of biomechanical forces and cellular interactions within the liver microenvironment.
• Evaluation of liver cell-specific functions in 3D culture systems.

Main Results:

• 3D models highlight the critical role of cell-matrix biomechanics in liver fibrosis.
• Complex interactions between HSCs, hepatocytes, and other non-parenchymal cells are elucidated.
• These models improve the understanding of liver cell functions relevant to fibrosis.

Conclusions:

• Refined 3D in vitro models accurately reproduce the liver microenvironment.
• These advanced models offer new objectives for antifibrotic drug discovery.
• A new era in the search for effective antifibrogenic compounds is anticipated.